Leukocyte telomere length and mortality risk in patients with type 2 diabetes

Oncotarget

Volumn 7, Issue 32, 2016, Pages 50835-50844

  Bonfigli, Anna Rita ^a   Spazzafumo, Liana ^a   Prattichizzo, Francesco ^b   Bonafè, Massimiliano ^c   Mensà, Emanuela ^a   Micolucci, Luigina ^d   Giuliani, Angelica ^d   Fabbietti, Paolo ^a   Testa, Roberto ^a   Boemi, Massimo ^a   Lattanzio, Fabrizia ^a   Olivieri, Fabiola ^a,d  

^a INRCA   (Italy)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Aging; Gerotarget; Mortality; Telomere shortening; Type 2 diabetes

Indexed keywords

CREATININE;

AGE; AGED; ARTICLE; CELLULAR PARAMETERS; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; FOLLOW UP; GENDER; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSTIC ASSESSMENT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; ADULT; GENETIC MARKER; GENETICS; KAPLAN MEIER METHOD; LEUKOCYTE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TELOMERE;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTES; MALE; MIDDLE AGED; PROGNOSIS; TELOMERE;

EID: 84982286100     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10615     Document Type: Article

References (54)

1. Lu W, Zhang Y, Liu D, Songyang Z, Wan M. Telomeresstructure, function, and regulation. Exp Cell Res. 2013;319:133-141.
2. Rhee DB, Ghosh A, Lu J, Bohr VA, Liu Y. Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair (Amst). 2011;10:34-44 doi: 10.1016/j.dnarep.2010.09.008.
3. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
4. Shay JW, Wright WE. Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol. 2000;1:72-6.
5. Campisi, J., Kim, S.H., Lim, C.S., Rubio, M., 2001. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 36, 1619-1637.
6. von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. CurrMol Med 2005;5:197-203
7. Tackney J, Cawthon RM, Coxworth JE, Hawkes K. Blood cell telomere lengths and shortening rates of chimpanzee and human females. Am J Hum Biol. 2014;26:452-460. doi: 10.1002/ajhb.22538.
8. Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350:1193-1198.
9. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and metaanalysis. BMJ. 2014;349:g4227.
10. Hunt SC, Kark JD, Aviv A. Association between shortened leukocyte telomere length and cardio-metabolic outcomes. Circ Cardiovasc Genet. 2015;8:4-7.
11. Reddel RR. Telomere maintenance mechanisms in cancer: clinical implications. Curr Pharm Des. 2014;20:6361-74.
12. Ma SL, Lau ES, Suen EW, Lam LC, Leung PC, Woo J, Tang NL. Telomere length and cognitive function in southern Chinese community-dwelling male elders. Age Ageing. 2013;42:450-455.
13. Zhao J, Miao K, Wang H, Ding H, Wang DW. Association between telomere length and type 2 diabetes mellitus: a meta-analysis. PLoS One. 2013;8:e79993.
14. Willeit P, Raschenberger J, Heydon EE, Tsimikas S, Haun M, Mayr A, Weger S, Witztum JL, Butterworth AS, Willeit J, Kronenberg F, Kiechl S. Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis. PLoS One. 2014 Nov 12;9:e112483.
15. Elks CE, Scott RA. The long and short of telomere length and diabetes. Diabetes. 2014;63:65-7.
16. Révész D, Milaneschi Y, Verhoeven JE, Penninx BW. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome. J Clin Endocrinol Metab. 2014;99:4607-15. doi: 10.1210/ jc.2014-1851.
17. Révész D, Milaneschi Y, Verhoeven JE, Lin J, Penninx BW. Longitudinal Associations Between Metabolic Syndrome Components and Telomere Shortening. J Clin Endocrinol Metab. 2015;100:3050-3059. doi: 10.1210/JC.2015-1995.
18. Sharma R, Gupta A, Thungapathra M, Bansal R. Telomere mean length in patients with diabetic retinopathy. Sci Rep. 2015;5:18368. doi: 10.1038/srep18368.
19. Olivieri F, Lorenzi M, Antonicelli R, Testa R, Sirolla C, Cardelli M, Mariotti S, Marchegiani F, Marra M, Spazzafumo L, Bonfigli AR, Procopio A. Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction. Atherosclerosis. 2009;206:588-93.
20. Verzola D, Gandolfo MT, Gaetani G, Ferraris A, Mangerini R, Ferrario F, Villaggio B, Gianiorio F, Tosetti F, Weiss U, Traverso P, Mji M, Deferrari G, et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 2008; 295: F1563-F1573.
21. Testa R, Olivieri F, Sirolla C, Spazzafumo L, Rippo MR, Marra M, Bonfigli AR, Ceriello A, Antonicelli R, Franceschi C, Castellucci C, Testa I, Procopio AD. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabet Med. 2011;28:1388-94.
22. Zhou MC, Min R, Ji JJ, Zhang S, Tong AL, Xu JP, Li ZY, Zhang HB, Li YX. Analysis of association among clinical features and shorter leukocyte telomere length in mitochondrial diabetes with m.3243A>G mitochondrial DNA mutation. BMC Med Genet. 2015;16:92. doi: 10.1186/s12881-015-0238-2.
23. Zhao J, Zhu Y, Lin J, Matsuguchi T, Blackburn E, Zhang Y, Cole SA, Best LG, Lee ET, Howard BV. Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study. Diabetes. 2014;63:354-62. doi: 10.2337/db13-0744.
24. Menke A, Casagrande S, Cowie CC. Leukocyte telomere length and diabetes status, duration, and control: the 1999-2002 National Health and Nutrition Examination Survey. BMC Endocr Disord. 2015;15:52. doi: 10.1186/s12902-015-0050-1.
25. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003; 361:393-5.
26. Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011;66:421-429.
27. Svensson J, Karlsson MK, Ljunggren Ö, Tivesten Å, Mellström D, Movérare-Skrtic S. Leukocyte telomere length is not associated with mortality in older men. Exp Gerontol. 2014;57:6-12. doi: 10.1016/j.exger.2014.04.013.
28. Deelen J, Beekman M, Codd V, Trompet S, Broer L, Hägg S, Fischer K, Thijssen PE, Suchiman HE, Postmus I, Uitterlinden AG, Hofman A, de Craen AJ, Metspalu A, Pedersen NL, van Duijn CM, Jukema JW, Houwing-Duistermaat JJ, Samani NJ, Slagboom PE. Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers. Int J Epidemiol. 2014;43:878-886. doi: 10.1093/ije/dyt267.
29. Rode L, Nordestgaard BG, Bojesen SE. Peripheral blood leukocyte telomere length and mortality among 64, 637 individuals from the general population. J Natl Cancer Inst. 2015;107:djv074. doi: 10.1093/jnci/djv074.
30. Houben JM, Giltay EJ, Rius-Ottenheim N, Hageman GJ, Kromhout D. Telomere length and mortality in elderly men: the Zutphen Elderly Study. J Gerontol A Biol Sci Med Sci. 2011;66:38-44. doi: 10.1093/gerona/glq164.
31. Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH. Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia. 2010;53:45-8.
32. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
33. Kelly PJ, Clarke PM, Hayes AJ, Gerdtham UG, Cederholm J, Nilsson P, Eliasson B, Gudbjornsdottir S. Predicting mortality in people with Type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data. Diabet Med. 2014;31:954-962.
34. Cox AJ, Hsu FC, Freedman BI, Herrington DM, Criqui MH, Carr JJ, Bowden DW. Contributors to mortality in high-risk diabetic patients in the Diabetes Heart Study. Diabetes Care. 2014;37:2798-803.
35. Zhang Y, Niu J, Choi HK. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med. 2016;374:788. doi: 10.1056/NEJMc1515130#SA2.
36. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013; 6;153:1194-217. doi: 10.1016/j.cell.2013.05.039.
37. Mitnitski A, Rockwood K. The rate of aging: the rate of deficit accumulation does not change over the adult life span. Biogerontology. 2016 Feb;17:199-204. doi: 10.1007/ s10522-015-9583-y.
38. Toraño EG, García MG, Fernández-Morera JL, Niño-García P, Fernández AF. The Impact of External Factors on the Epigenome: In Utero and over Lifetime. Biomed Res Int. 2016;2016:2568635. doi: 10.1155/2016/2568635.
39. Spazzafumo L, Olivieri F, Abbatecola AM, Castellani G, Monti D, Lisa R, Galeazzi R, Sirolla C, Testa R, Ostan R, Scurti M, Caruso C, Vasto S, Vescovini R, Ogliari G, Mari D, Lattanzio F, Franceschi C. Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes. Age (Dordr). 2013;35:419-429. doi: 10.1007/s11357-011-9348-8.
40. Perkisas S, Vandewoude M. Where frailty meets diabetes. Diabetes Metab Res Rev. 2015. doi: 10.1002/dmrr.2743.
41. Wong JY, De Vivo I, Lin X, Fang SC, Christiani DC. The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One. 2014;9:e87348. doi: 10.1371/journal.pone.0087348.
42. Donath MY. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Diabetologia. 2016;59:679-82 doi: 10.1007/s00125-016-3873-z.
43. Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity. Diabetes. 2015;64:2289-2298. doi: 10.2337/db14-1820.
44. Prattichizzo F, Giuliani A, Ceka A, Rippo MR, Bonfigli AR, Testa R, Procopio AD, Olivieri F. Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes. Clin Epigenetics. 2015;7:56. doi: 10.1186/s13148-015-0090-4.
45. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to ageassociated diseases. J Gerontol A Biol Sci Med Sci. 2014;69 Suppl 1:S4-9. doi: 10.1093/gerona/glu057.
46. Olivieri F, Albertini MC, Orciani M, Ceka A, Cricca M, Procopio AD, Bonafè M. DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging. Oncotarget. 2015;6:35509-35521. doi: 10.18632/oncotarget.5899.
47. Wang Z, Deng Z, Dahmane N, Tsai K, Wang P, Williams DR, Kossenkov AV, Showe LC, Zhang R, Huang Q, Conejo-Garcia JR, Lieberman PM. Telomeric repeatcontaining RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes. Proc Natl Acad Sci U S A. 2015;112:E6293-300. doi: 10.1073/ pnas.1505962112
48. Cusanelli E, Romero CA, Chartrand P. Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol Cell. 2013;51:780-91. doi: 10.1016/j.molcel.2013.08.029.
49. Salpea KD, Humphries SE. Telomere length in atherosclerosis and diabetes. Atherosclerosis. 2010;209:35-8 doi: 10.1016/j.atherosclerosis.2009.12.021.
50. Strazhesko I, Tkacheva O, Boytsov S, Akasheva D, Dudinskaya E, Vygodin V, Skvortsov D, Nilsson P.Association of Insulin Resistance, Arterial Stiffness and Telomere Length in Adults Free of Cardiovascular Diseases. PLoS One. 2015;10:e0136676.
51. De Tata V. Age-related impairment of pancreatic Betacell function: pathophysiological and cellular mechanisms. Front Endocrinol (Lausanne). 2014;5:138. doi: 10.3389/ fendo.2014.00138.
52. Tamura Y, Takubo K, Aida J, Araki A, Ito H. Telomere attrition and diabetes mellitus. Geriatr Gerontol Int. 2016;16 Suppl 1:66-74. doi: 10.1111/ggi.12738.
53. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30: S42-S47.
54. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.